Crossmark

Efficacy and safety of Chinese patent medicines for allergic rhinitis based on 2020 Chinese Pharmacopoeia: a protocol for systematic review and meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s13643-024-02748-1

Published Online: 2025-03-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Weibo

Kong, Lingyao

Wang, Xuehui

Liu, Qingyuan

Wang, Yaqi

Wang, Ji
License Information

Text and Data Mining valid from 2025-03-24

Version of Record valid from 2025-03-24
More Information

Article History

Received: 19 September 2024

Accepted: 20 December 2024

First Online: 24 March 2025

Declarations

:

: Human research ethics committee approval is not required for this review as no original primary data will be collected.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below